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Ultrasound in the Prediction of
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Background: A reliable interpretation of uroflowmetry depends on adequate voiding
volume. Unfortunately, many patients may not be in a position to void enough volume
to allow an effective interpretation. The main objective of this study was to determine
how a valuable uroflow rate can be obtained with an inadequate or even no voiding
volume. We have tried to develop a new method to predict the actual uroflow rate by
adding power Doppler information during transrectal ultrasound (TRUS) in patients who
do not have an interpretable voiding volume.
Patients and Methods: Fifty-five patients with complete uroflowmetry and TRUS with
power Doppler study were enrolled. Analyses of the uroflowmetry and power Doppler
parameters were performed. Correlation coefficients were calculated to reveal the relation-
ships among these parameters.
Results: The correlation coefficient between the prostate intracapsular pulsatility index
(PI) and corrected peak flow rate (cQmax) was –0.79. Correlation between the PI of vessels
outside the prostate and cQmax was not significant, as the intracapsular PI was. We
generated a linear regression equation, cQmax = 0.8911 × PI + 14.569, to predict cQmax
by intracapsular PI. This equation can be applied when adequate spontaneous voiding
is not available.
Conclusion: TRUS is informative when power Doppler parameters are applied. Corrected
peak uroflow rate can be predicted even in patients who have an inadequate or no voiding
volume.
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Introduction
Application of urodynamic study in a series of follow-
up studies of the severity and treatment results of
benign prostate obstruction (BPO) has proven to
be effective [1,2]. Pressure-flow study is recognized
as the only precise method for the diagnosis of out-
flow obstruction [3]. However, it is time-consuming
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and the patient’s cooperation is mandatory. A sim-
ple test, such as uroflowmetry at the outpatient clin-
ic, may provide basic and necessary information.
However, the main limitation of uroflowmetry is
its inability to differentiate between poor detrusor
function and bladder outlet obstruction [4]. In
addition, the result is reliable only when the voiding
volume is more than 125–150 mL. In fact, some
patients with frequency and urgency are hardly
able to retain this quantity for uroflowmetry. It
is also difficult to complete the study if the patient
is less than cooperative; patients with psychiatric
problems or cerebral vascular insult may have dif-
ficulty participating in urodynamic study.
Transrectal ultrasound (TRUS) also plays an im-
portant role in the diagnosis and treatment of BPO.
It can provide definite evidence of a large obstruc-
tive prostate prior to further invasive surgeries [5].
Although Gotoh et al’s study showed that prostate
size is not related to peak urinary flow rate [6], the
transitional zone index (TZI) shows a relationship be-
tween benign prostate symptoms and peak uroflow
rate [7]. Theoretically, the transitional zone, where
the urinary flow passes, has the greatest effect on
voiding. Since the obstruction of flow is related only
to the size and ratio of the transitional zone, it may
also be concluded that only certain parts of the
prostate structure affect the passage of uroflow.
Factors affecting urinary flow may also affect other
physiologic conditions, such as hemodynamics with-
in the prostate. Therefore, the relationship between
the hemodynamic status of the prostate and the
urodynamic status of uroflow was investigated.
The value of power Doppler ultrasound in pre-
dicting the uroflow pattern was demonstrated. If
prostate hemodynamics is related to urodynamics,
a single TRUS study may provide information about
prostate size, TZI, blood flow profiles and related
uroflow prediction. This would also be a suitable
method for screening at outpatient clinics.
Patients and Methods
Patients who were proven to have prostate cancer,
by prostate biopsy or accidentally found in transure-
thral resects, were excluded from this study. A total
of 55 patients with complete uroflow and hemo-
dynamic studies were investigated during the period
of March 2003 to December 2004. Their mean age
was 69.3 ± 10.5 years (range, 40–93 years). The
major causes for referral were elevated prostate-
specific antigen, lower urinary tract symptoms, and
abnormal findings in digital rectal examination,
hematospermia, or chronic pelvic pain syndrome.
Patients’ voiding symptoms were recorded using
International Prostate Symptom Scores (IPSS). Uro-
flow study (UD-2000; Medical Measurement Sys-
tems, Enschede, The Netherlands) and TRUS were
the main tools for investigation of the prostate.
Three-dimensional ultrasound (LOGIQ® 9, E8C
type probe; GE Medical Systems, Milwaukee, WI,
USA) was used to evaluate prostate size and general
information of the wave spectrum. The total pros-
tate volume was calculated along with the transi-
tional zone volume by retrieving the width, height,
and length of the whole prostate and transitional
zone. Blood flow parameters within the prostate
transitional zone and periprostatic areas were
demonstrated under color flow mapping. The
peak systolic velocity (PSV), end diastolic velocity
(EDV), time-averaged maximum velocity (TAMAX),
pulsatility index (PI), resistive index (RI), and dias-
tole/systole ratio (EDV/PSV) were calculated auto-
matically by the computer using the raw data of
the blood flow. Gating of Doppler parameters was
focused on bilateral transitional zones, bilateral
neurovascular bundles and vessels located near the
border of the transitional zone. Prominent blood
flow within the peripheral zone, surrounding dis-
crete prostate lesions, and vessels, penetrating major
lesions, were also specified and evaluated.
Patients enrolled in this study had undergone
complete uroflowmetry. Since most patients pre-
sented with some kind of voiding symptoms, uro-
flow study was often performed a couple of days
(range, 0–10 days) before TRUS. Uroflowmetry was
done using a flowmeter (UD-2000; Medical Meas-
urement Systems). The post voiding residual was
checked with either catheterization or bladder scan
D.R. Ho, C.F. Wu, J.J. Shee, et al
J Med Ultrasound 5200 • Vol 13 • No 262
(BladderScan®; Diagnostic Ultrasound, Bothell, WA,
USA). Urodynamic parameters including peak flow
rate (Qmax), average flow rate (Qave), corrected peak
flow rate (cQmax), voiding volume, voiding time,
and residual volume were collected for comparison.
Secondary parameters, including total bladder
capacity, which is the sum of residual urine and
voiding volume, and TZI, which is the ratio of tran-
sitional zone volume over total prostate volume,
were also calculated.
The 55 patients with complete color Doppler
sonography of the prostate and uroflow measure-
ments were classified into different groups according
to their voiding volume (> 100 mL or > 200 mL).
The correlation coefficients among the urodyna-
mic and hemodynamic parameters were analyzed.
These parameters were also analyzed to understand
the differences among hemodynamic profiles from
different areas of the prostate (intracapsular or
extracapsular).
Results
The urodynamic and hemodynamic parameters of
the 55 patients are summarized in Table 1. Strat-
ification of patients by voiding volume was im-
portant to achieve significance in this study. The
voiding volume-stratified correlation coefficients
between TZI and PI or cQmax are shown in Table
2. It was found that if a patient voids a small amount
of urine during uroflowmetry, then it is less likely
to represent the patient’s actual condition. Since
TZI has been well recognized as an indicator of BPO
severity, a comparison of TZI with the urodynamic
profiles of each patient was made. It showed that
TZI was closely correlated with cQmax. The correla-
tion coefficient was –0.39 when voiding volume
exceeded 200 mL. This was compatible with the
previous conclusion of Kaplan et al [7]. The larger
the TZI, the smaller the cQmax. Also, the larger the
voiding volume, the higher the correlation between
TZI and cQmax. In addition, the correlation coefficient
between TZI and PI was also relatively high: –0.32.
The relationship was of significance in the group
of patients with voiding volume > 200 mL.
On further investigation of the relationship be-
tween urodynamic and hemodynamic profiles, it
was found that intracapsular PI was closely related
with cQmax (correlation coefficient = 0.79). The hemo-
dynamic profiles vary in different parts of the pros-
tate. We attempted to determine the relationship
between the PI of vessels lying outside the prostate
(neurovascular bundle profiles) and cQmax, and found
that the correlation coefficient of extracapsular ves-
sel PI and cQmax was 0.38 (Table 3). It did not appear
to relate well with voiding volume. The blood flow
Table 1. Urodynamic and hemodynamic parameters of the 55 patients
Qmax VV RU Qave cQmax PS PI RI TAMAX
Mean 11.24 141.10 075.25 04.56 11.02 18.73 1.37 0.67 10.41
SD 10.89 101.44 108.07 03.74 04.45 08.25 1.33 0.11 05.19
Max 74.00 566.00 565.00 25.00 24.00 51.49 9.68 1.00 24.99
Min 00.00 000.00 000.00 00.00 00.00 07.59 0.42 0.48 01.35
Q
max
= peak uroflow rate; VV = voiding volume; RU = residual urine; Q
ave
= average uroflow rate; cQ
max
= corrected peak uroflow rate; PS =
peak systolic velocity; PI = pulsatility index; RI = resistive index; TAMAX = time-averaged maximal velocity; SD = standard deviation; Max = maximal;
Min = minimal.
Table 2. Correlation coefficient between
transitional zone index (TZI) and pulsatility index
(PI) or corrected peak uroflow rate (cQmax),
stratified by voiding volume (VV)
TZI PI cQmax
All VV –0.04 –0.25
> 100 mL –0.09 –0.17
> 200 mL –0.32 –0.39
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in the neurovascular bundle did not show as close
a relationship as the blood flow within the prostate
(transitional zone profiles). A linear regression equa-
tion was generated: cQmax = 0.8911 × PI + 14.569
(Fig.).
Discussion
TZI, the ratio between the transitional zone and
total prostate volume, has been shown to be a use-
ful parameter to evaluate the severity of urinary
obstruction in BPO [7]. It has been established
that a TZI of 0.5 is a good cut-off point to delineate
patients with more severe symptoms. This indi-
cated that the prostate structure could be repre-
sented with hemodynamic changes, and thus af-
fected the symptoms in voiding. In addition, TZI
is considered to be a good predictor of the treat-
ment efficacy of transurethral resection of the pros-
tate [8]. In fact, the transitional zone, where the
urinary flow passes, is more closely related with Qmax
and symptom scores than with total prostate volume.
These indicate that uroflow rate is affected mainly
by the area of maximal resistance along the pros-
tatic urethra. The structural and physiologic char-
acteristics of the prostatic urethra may have a greater
effect on voiding.
Power Doppler ultrasound of the prostate has
proven to be a useful clinical tool. The RI calculated
by the Doppler wave spectrum is a useful predictor
of efficacy under the treatment of alpha-blocker [9].
Power Doppler ultrasound also revealed a correla-
tion between IPSS and RI of the capsular artery [10].
It indicates that prostate hemodynamic status, meas-
ured by power Doppler ultrasound, may imply the
urodynamic status of urinary flow.
Local blood flow of the prostate was reported
to be associated with the severity of BPO. Micro-
circulation was increased in BPO and could be in-
fluenced by 5-alpha reductase inhibitor [11]. The
growth of prostate adenoma was associated with
increased blood supply. This may indicate the close
relationship between anatomic structure and local
blood perfusion within the prostate. The effect of
androgen deprivation caused by 5-alpha reductase
inhibitor may result in a significant decrease in
prostate volume [12], which is a significant change
in structure. Using power Doppler waveform, in-
formation on the blood flow in the prostate can
be obtained. With these physiologic and anatomic
parameters that were retrieved from TRUS, a clear
picture of the processes within the prostate during
voiding can be obtained.
During the process of prostate hyperplasia, the
pressure within the transitional zone may rise as the
inner mass increases. Increasing soft tissue within
an intact prostate capsule would result in confor-
mational change in the globular shape of the pros-
tate. Increased pressure within the capsule would
Table 3. Correlation coefficient between corrected
peak uroflow rate (cQ
max
) and pulsatility index
(PI) at different vessel locations, stratified by
voiding volume (VV)
cQmax PI in left TZ PI in left NVB
All VV 0.48 0.38
> 100 mL 0.61 0.40
> 200 mL 0.79 0.38
TZ = transitional zone; NVB = neurovascular bundle.
Fig. Linear regression to predict peak flow rate by pulsatility
index.
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be inevitable. Although the microvascular density
may increase in this hypercellular area to sustain
the hyperplasia of the prostate [13,14], the hemo-
dynamic status of these vessels would still bear
the same pressure in this area that has resulted from
tissue overgrowth. The pressure on the prostatic
urethra, indirectly represented with vascular resis-
tance, would affect urinary flow. Although a pre-
vious study showed that urethral elasticity can-
not be predicted by the morphologic changes [15],
positive relationships among transitional zone size,
peak urinary flow and PI in BPO patients can be
seen after carefully stratifying these patients and
discriminating each factor.
The pattern of blood flow within the prostate
is important. Vessels perforating the prostate cap-
sule, so-called capsular efferent, is an indicator of
extracapsular involvement of the prostate cancer
[16]. Prostate hemodynamics change in a cancer
patient, which may be the result of changes in vessel
distribution. The different patterns of vessel dis-
tribution in the prostate can assist sextant biopsy
for prostate cancer. We found that there is a similar
occurrence in BPO patients. Blood supply of the
prostate, especially in the transitional zone, would
also have changed during the development of pros-
tate hyperplasia and obstruction. Therefore, there
may be some differences in the hemodynamic pro-
files of the prostate. To further differentiate the
differences in blood flow, the intracapsular and ex-
tracapsular vessels, designated respectively as the
transitional zone and neurovascular bundle, were
analyzed separately. This stratification may provide
adequate information about the different blood flow
patterns within and outside the prostate.
From our study, the blood flow within the left
side of the prostate, noted as the profile of the left
transitional zone, had a higher correlation (0.79)
between PI and cQmax than the hemodynamic pro-
file in the left neurovascular bundle (0.38). This
may indicate that the pressure within the prostate
capsule, especially within the transitional zone, may
compress the urethra and vessels inwards. There-
fore, the higher the pressure within the transitional
zone, the lower the voiding Qmax and PI on the same
side. On the contrary, for vessels located outside the
prostate capsule, there was less correlation between
PI and cQmax, although they were otherwise asso-
ciated. By comparing with Tsuru et al’s study on
prostate capsular arterial RI and TZI [10], it was
believed that PI would be a better index of cQmax
and TZI. Therefore, a linear regression equation,
cQmax = 0.8911 × PI + 14.569, was generated to
predict cQmax using intracapsular PI. This equation
can be applied especially when spontaneous void-
ing is not available.
The above discussion is based on a simple hypo-
thesis. The patient must void more than 200 mL
to reveal this relationship. If the voiding volume is
less than 200 mL, a random distribution of plots
in the linear regression figure of PI and cQmax is
found. Reliability of urodynamic studies depends on
adequate voiding volume [17,18]. This means that
it is difficult to accurately determine the true flow
rate of voiding if voiding volume is not adequate.
In our study, the correlation coefficient, while strati-
fied by voiding volume, between TZI and PI or cQmax
was –0.32 vs. –0.39, respectively. The linear re-
lationship exists only when the voiding volume is
more than 200 mL.
Power Doppler ultrasonography can show dif-
ferent patterns of blood flow mapping within the
prostate. Pulsating vessels are seen mainly within
the transitional zone and outside the prostate,
but they are not the same. Blood flow at a certain
location may not be detected. The blood flow pro-
files on the pulsating vessels can be evaluated. All
hemodynamic parameters vary, and the variations
seem to be larger between patients than within
the same patient. There are also more variations
between intracapsular and extracapsular vessels in
the same patient than in the left and right side ves-
sels. With the introduction of new modes of ultra-
sonography, blood flow mapping is improved and
easily detected. The analysis is performed based on
the blood flow of a specific location, such as the
transitional zone or neurovascular bundle. The ma-
jor shortcoming of power Doppler wave spectrum
evaluation may be the inconsistencies in data as
a result of different operators. Differences in intra-
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cranial power Doppler parameters have been eva-
luated in Unal et al’s study [19]. It is also difficult
to avoid these problems in the prostate. However,
two steps can be taken to reduce these biases. First,
nearly all of the power Doppler parameters are
gathered automatically. All that needs to be done
is to precisely focus the target area. An automatic
built-in calculator would generate all the parameters
when the waveforms are complete. If the waveforms
are not properly collected, marks would have to be
set manually. This may be the major cause of bias
and the absence of observable waveform may also
occur. It is not always possible to acquire all power
Doppler parameters in all the expected areas of the
prostate. Second, most of the TRUS scans should
be performed by a single physician. This can min-
imize interoperator variance.
Conclusion
There are various ways to diagnose bladder outlet
obstruction. A previous study has shown that the
combination of prostate size, maximal urine flow
rate and residual urine can diagnose obstruction in
men with BPO, with a reliability of over 90% [20].
With the study of correlations among urodynamics,
hemodynamics and prostate size, we have presented
a way to predict obstruction by employing a simple
method of power Doppler TRUS of the prostate.
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